Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Applied DNA Sciences' CEO Discusses F1Q13 Results - Earnings Call Transcript
Seeking Alpha
Saturday, February 16, 2013 - 11:22am
tags:
Applied DNA Sciences, earnings
Forbes Earnings Preview: InterMune, Inc.
Forbes
Saturday, February 16, 2013 - 11:21am
tags:
InterMune, earnings
Stem Cells Have a Long Way to Go
Motley Fool
Saturday, February 16, 2013 - 11:20am
tags:
stem cells, HuCNS-SC, StemCells
Questcor - Short Squeeze Starting
Seeking Alpha
Saturday, February 16, 2013 - 11:18am
tags:
Questcor Pharmaceuticals
Eylea Drives Regeneron
Yahoo/Zacks
Saturday, February 16, 2013 - 11:17am
tags:
Eylea, Regeneron, macular degeneration, macular edema
Incyte Earnings: Here’s Why Investors are Happy Now
Wall St. Cheat Sheet
Friday, February 15, 2013 - 11:43am
tags:
earnings, Incyte
Transcept: The Prescription Trend Watch For Intermezzo Is On
Seeking Alpha
Friday, February 15, 2013 - 11:42am
tags:
Transcept, Intermezzo, insomnia
Peregrine's Epic Failure (Maybe)
Motley Fool
Friday, February 15, 2013 - 11:42am
tags:
Peregrine Pharmaceuticals, pancreatic cancer, bavituximab
ImmunoGen Progresses with IMGN901
Yahoo/Zacks
Friday, February 15, 2013 - 11:41am
tags:
Immunogen, IMGN901, small cell lung cancer
Earnings Beat at Actelion
Yahoo/Zacks
Friday, February 15, 2013 - 11:30am
tags:
earnings, Actelion
2013 GU: Dendreon's Neuvenge, A First Look At The Clinical Trial Results
Seeking Alpha
Friday, February 15, 2013 - 11:28am
tags:
Dendreon, Neuvenge, urothelial cancer
AbbVie board OKs $1.5B for share buybacks
Yahoo/AP
Friday, February 15, 2013 - 11:27am
tags:
AbbVie, share repurchase
GSK wins priority status for new HIV drug in U.S.
Reuters
Friday, February 15, 2013 - 11:23am
tags:
GSK, HIV, Shionogi, ViiV Healthcare, Dolutegravir
Eisai gets orphan drug status for Lenvatinib
Marketwatch
Friday, February 15, 2013 - 11:09am
tags:
Eisai, orphan drugs, Lenvatinib, thyroid cancer
U.S. appeals court finds Astra's Seroquel XR patent infringed
Reuters
Friday, February 15, 2013 - 11:05am
tags:
Astra Zeneca, Seroquel XR, patents, Mylan
Mylan in exclusive talks to buy Strides Arcolab’s injectables unit
Economic Times, India
Friday, February 15, 2013 - 11:02am
tags:
Strides Arcolab, Mylan, injectables, M&A
Congress Tells FDA To Reclassify Painkillers Now
Pharmalot
Friday, February 15, 2013 - 11:01am
tags:
congress, FDA, painkillers, hydrocodone
The Meat and Potatoes of Abbott Labs
Motley Fool
Friday, February 15, 2013 - 10:59am
tags:
Abbott Labs, AbbVie
Genmab Rises as Danske Sees FDA Breakthrough: Copenhagen Mover
Bloomberg
Friday, February 15, 2013 - 10:58am
tags:
Genmab, FDA, daratumumab
Zoetis - Successful Offering Fails To Lift Pfizer's Shares
Seeking Alpha
Friday, February 15, 2013 - 10:44am
tags:
Zoetis, animal health, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.